August 15, 2025

Approved: HPV-Targeted Immunotherapy for Recurrent Respiratory Papillomatosis

Standard management has relied on repeated surgical debulking, which does not eradicate underlying HPV infection.

Conexiant

August 15, 2025

COVID-19 Booster in Pregnancy Linked to Higher Infant Antibodies

A COVID-19 mRNA booster given during pregnancy is associated with greater transplacental antibody transfer and sustained infant antibody levels through 6 months of age.

Conexiant

August 12, 2025

FDA Approves First Therapy for Non-cystic Fibrosis Bronchiectasis

Brensocatib (Brinsupri) will offer a new treatment option for patients 12 years and older.

Conexiant

August 12, 2025

Advanced-Practice Providers Filling Rural ER Gaps

Rural emergency rooms across the U.S. are increasingly staffed by physician assistants and nurse practitioners instead of physicians, raising debates over care quality, staffing shortages, and access to emergency services.

KFF Health News

August 11, 2025

FDA OKs Bioequivalent Iron Sucrose for CKD Anemia

The FDA has approved a bioequivalent iron sucrose injection for treating iron deficiency anemia in patients with chronic kidney disease.

Conexiant

August 04, 2025

Acupuncture Review Targets IgA Vasculitis Pain

Researchers will systematically review the efficacy and safety of acupuncture for abdominal pain in IgA vasculitis, aiming to inform clinical practice.

Conexiant

August 01, 2025

Dynamic Splinting More Effective Than Diapering in Infant Hip Development

A new study combining cohort data and meta-analysis found that dynamic splinting and double diapering were more effective than observation for improving alpha angle and hip maturation in infants under 6 months old.

Conexiant

July 31, 2025

AAP Releases 2025-2026 Flu Guidance

Experts encourage early influenza vaccination in children to reduce severe illness and hospitalization, especially among medically vulnerable and underserved populations.

Conexiant

July 30, 2025

Ondansetron Cuts 7-Day Gastroenteritis Severity in Children, Study Finds

Home use of ondansetron following emergency care for pediatric gastroenteritis lowers the risk of moderate-to-severe illness within 7 days, without increasing serious adverse events.

Conexiant